{{Rsnum
|rsid=7652331
|Gene=FYCO1
|Chromosome=3
|position=45921260
|Orientation=plus
|GMAF=0.1511
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FYCO1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 38.9 | 14.2
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 96.6 | 3.4 | 0.0
| ASW | 82.5 | 12.3 | 5.3
| CHB | 99.3 | 0.7 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 25.7 | 52.5 | 21.8
| LWK | 90.8 | 9.2 | 0.0
| MEX | 86.2 | 13.8 | 0.0
| MKK | 88.5 | 10.9 | 0.6
| TSI | 55.9 | 41.2 | 2.9
| HapMapRevision=28
}}
[[rs7652331]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (T); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=4.4 x 10e-5, using a dominant model of risk.{{PMID|18073375}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}